General Information
Version
2.1
Revision date
2023-04-18
Product name
Helimatic Neutralizer C
1.2.1 Relevant identified uses
Neutralising agent
supplier name
B. Braun Medical AG
Manufacturer Name
B. Braun Medical AG
Emergency telephone
+49 - (0) 6132 - 84463
Icons in SDS
Company Information
company name
B. Braun Medical AG
e-mail address of the competent person responsible for the Safety Data Sheet
info.bbmch@bbraun.com, logistics.service@bbraun.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319, H335
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Causes serious eye irritation. May cause respiratory irritation.
2.2 Label elements
Labelling
Signal word
Warning Warning
Contains
Citric acid monohydrate
Hazard statements
H319 - Causes serious eye irritation. H335 - May cause respiratory irritation.
Precautionary statements
P280 - Wear protective gloves, protective clothing, eye protection, face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P501 - Dispose of contents and container to an approved waste disposal plant. Labelling according to: exemption for packages of a capacity of 125ml or less
Hazard pictograms
GHS07
Hazardous Ingredients
Citric acid monohydrate
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %